GATA4 and atrial septal defect: This is especially relevant in rare but well-known patients with genetic predispositions to LV cardiomyopathy, with or without ASD-related mutations (e.g. NKX2.5, GATA4, or TBX5 (ASD-linked), or sarcomeric mutations (non-ASD-linked)).